[
  {
    "ts": null,
    "headline": "Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing",
    "summary": "In the closing of the recent trading day, Medtronic (MDT) stood at $83.62, denoting a +0.55% change from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=cd0eac677e94de76e58272d49d46101e22d983362c8b89afba88a7a30a2f234b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746740706,
      "headline": "Medtronic (MDT) Rises Yet Lags Behind Market: Some Facts Worth Knowing",
      "id": 134335956,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Medtronic (MDT) stood at $83.62, denoting a +0.55% change from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=cd0eac677e94de76e58272d49d46101e22d983362c8b89afba88a7a30a2f234b"
    }
  },
  {
    "ts": null,
    "headline": "Is Medtronic Stock a Buy Pre-Q4 Earnings? Key Metrics to Watch",
    "summary": "Despite challenges, Medtronic demonstrates the resilience of its underlying business fundamentals, delivering consistent mid-single-digit organic revenue growth.",
    "url": "https://finnhub.io/api/news?id=f559be18fdd2c43d4fe0a1faa38e245098ceec20dda6b057845318aa62d9b314",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746730800,
      "headline": "Is Medtronic Stock a Buy Pre-Q4 Earnings? Key Metrics to Watch",
      "id": 134335957,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Despite challenges, Medtronic demonstrates the resilience of its underlying business fundamentals, delivering consistent mid-single-digit organic revenue growth.",
      "url": "https://finnhub.io/api/news?id=f559be18fdd2c43d4fe0a1faa38e245098ceec20dda6b057845318aa62d9b314"
    }
  },
  {
    "ts": null,
    "headline": "With Competition Rising, Should Investors Give Up On This Top Growth Stock?",
    "summary": "Intuitive Surgical has had little competition for its famous da Vinci system in the U.S.  Intuitive Surgical (NASDAQ: ISRG) has delivered market-crushing returns over the past two decades, thanks to its leadership in the robotic-assisted surgery (RAS) market.  Part of the company's appeal is that its crown jewel has had little competition.",
    "url": "https://finnhub.io/api/news?id=e626c4ae99640891024e7b31a7e6b7badb0f35b8c347e599c2b4bb93129a5e7c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746704700,
      "headline": "With Competition Rising, Should Investors Give Up On This Top Growth Stock?",
      "id": 134325295,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Intuitive Surgical has had little competition for its famous da Vinci system in the U.S.  Intuitive Surgical (NASDAQ: ISRG) has delivered market-crushing returns over the past two decades, thanks to its leadership in the robotic-assisted surgery (RAS) market.  Part of the company's appeal is that its crown jewel has had little competition.",
      "url": "https://finnhub.io/api/news?id=e626c4ae99640891024e7b31a7e6b7badb0f35b8c347e599c2b4bb93129a5e7c"
    }
  },
  {
    "ts": null,
    "headline": "Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates",
    "summary": "Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of 1.54% and 2.62%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=7eef8200f9e3981518fe1817819761a32e7a95096d10a782fb11424a6b4aa838",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746703205,
      "headline": "Prestige Consumer Healthcare (PBH) Tops Q4 Earnings and Revenue Estimates",
      "id": 134325394,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Prestige Consumer Healthcare (PBH) delivered earnings and revenue surprises of 1.54% and 2.62%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=7eef8200f9e3981518fe1817819761a32e7a95096d10a782fb11424a6b4aa838"
    }
  }
]